Keyword: Pharma & Biotech


Symeres Strengthens US Foothold with Exemplify Buy

27.10.2022 -

Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens...

Strategy & Management

Facing Strong Headwinds

14.09.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

Strategy & Management

Expansions in High-Potency API Manufacturing

14.09.2020 -

DCAT Value Chain Insights rounds up recent expansion activity for highly potent drug substances and drug products.

Chemistry & Life Sciences

Understanding the Requirements of Safe HPAPI Manufacturing

11.09.2020 -

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Chemistry & Life Sciences

The Rise of HPAPI Molecules

10.09.2020 -

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

Markets & Companies

Why CDMOs Should Consider Value-Based Pricing

13.09.2019 - Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model. In...

Research & Innovation

The Importance of On-line Process Control

10.09.2019 - Modern therapies of different diseases very often utilize drugs derived from living cells. However, manufacturing of these biopharmaceutical products is a complex process. One of...